Alzheimer’s Research Papers
Alvarez-Arcaya A, Combarros O, Llorca J, Sánchez-Guerra M, Berciano J, Fernández-Luna JL. The --491 TT apolipoprotein E promoter polymorphism is associated with reduced risk for sporadic Alzheimer's disease. Neurosci Lett. 2001 May 25;304(3):204-8. ,
Pérez M, Arrasate M, Montejo De Garcini E, Muñoz V, Avila J. In vitro assembly of tau protein: mapping the regions involved in filament formation. Biochemistry. 2001 May 22;40(20):5983-91.
Hashimoto Y, Niikura T, Tajima H, Yasukawa T, Sudo H, Ito Y, Kita Y, Kawasumi M, Kouyama K, Doyu M, Sobue G, Koide T, Tsuji S, Lang J, Kurokawa K, Nishimoto I. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta. Proc Natl Acad Sci U S A. 2001 May 22;98(11):6336-41.
Lefterov IM, Koldamova RP, Lefterova MI, Schwartz DR
Charlwood J, Dingwall C, Matico R, Hussain I, Johanson K, Moore S, Powell DJ, Skehel JM, Ratcliffe S, Clarke B, Trill J, Sweitzer S, Camilleri P. Characterization of the glycosylation profiles of Alzheimer's beta -secretase protein Asp-2 expressed in a variety of cell lines. J Biol Chem. 2001 May 18;276(20):16739-48.
Tong L, Thornton PL, Balazs R, Cotman CW. Beta -amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival Is not compromised. J Biol Chem. 2001 May 18;276(20):17301-6.
Skovronsky DM, Lee VM, Praticò D. Amyloid precursor protein and amyloid beta peptide in human platelets. Role of cyclooxygenase and protein kinase C. J Biol Chem. 2001 May 18;276(20):17036-43.
Mehta PD, Pirttila T, Patrick BA, Barshatzky M, Mehta SP. Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease. Neurosci Lett. 2001 May 18;304(1-2):102-6. ,
Brejc K, van Dijk WJ, Klaassen RV, Schuurmans M, van Der Oost J, Smit AB, Sixma TK. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature. 2001 May 17;411(6835):269-76.
Clarke RP. Incidence of dementia and Alzheimer disease in Nigeria and the United States. JAMA. 2001 May 16;285(19):2448-9.
Grant WB. Incidence of dementia and Alzheimer disease in Nigeria and the United States. JAMA. 2001 May 16;285(19):2448; discussion 2448-9.
Blennow K, Lind B, Andersson E, Andreasen N. [CSF-analyses in clinical diagnosis of Creutzfeldt-Jakob disease. A literature review and three cases from routine clinical practice] Lakartidningen. 2001 May 16;98(20):2446-51.
Jiménez Del Rio M, Vélez Pardo C. [Apoptosis in neurodegenerative diseases: facts and controversies] Rev Neurol. 2001 May 16;32(9):851-860.
Serrano Sánchez T, Robinson Agramonte Md , Lorigados Pedre L, Díaz Armesto I, González Fraguela ME, Dorta-Contreras AJ. [Endogenous nerve growth factor in patients with Alzheimer s disease] Rev Neurol. 2001 May 16;32(9):825-828.
Kawahara M, Kato M, Kuroda Y. Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein. Brain Res Bull. 2001 May 15;55(2):211-7.
Flaten TP. Aluminium as a risk factor in Alzheimer's disease, with emphasis on drinking water. Brain Res Bull. 2001 May 15;55(2):187-96.
Hidalgo J, Aschner M, Zatta P, Vasák M. Roles of the metallothionein family of proteins in the central nervous system. Brain Res Bull. 2001 May 15;55(2):133-45.
Strausak D, Mercer JF, Dieter HH, Stremmel W, Multhaup G. Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases. Brain Res Bull. 2001 May 15;55(2):175-85.
Solomon B, Koppel R, Jossiphov J. Immunostaining of calmodulin and aluminium in Alzheimer's disease-affected brains. Brain Res Bull. 2001 May 15;55(2):253-6.
Platt B, Fiddler G, Riedel G, Henderson Z. Aluminium toxicity in the rat brain: histochemical and immunocytochemical evidence. Brain Res Bull. 2001 May 15;55(2):257-67.
Turnbull S, Tabner BJ, El-Agnaf OM, Twyman LJ, Allsop D. New evidence that the Alzheimer beta-amyloid peptide does not spontaneously form free radicals: an ESR study using a series of spin-traps. Free Radic Biol Med. 2001 May 15;30(10):1154-62.
Lemonick MD, Park A. The nun study. How one scientist and 678 sisters are helping unlock the secrets of Alzheimer's. Time. 2001 May 14;157(19):54-9, 62, 64.
Larkin M. New US guidelines for Alzheimer's disease released. Lancet. 2001 May 12;357(9267):1505.
Sato Y, Naito Y, Grundke-Iqbal I, Iqbal K, Endo T. Analysis of N-glycans of pathological tau: possible occurrence of aberrant processing of tau in Alzheimer's disease. FEBS Lett. 2001 May 11;496(2-3):152-60.
Shukla C, Bridges LR. Tau, beta-amyloid and beta-amyloid precursor protein distribution in the entorhinal-hippocampal alvear and perforant pathways in the Alzheimer's brain. Neurosci Lett. 2001 May 11;303(3):193-7.
Sanchez DJ, Armstrong L, Aguilar R, Adrian GS, Haro L, Martinez AO. Haptoglobin gene expression in human glioblastoma cell lines. Neurosci Lett. 2001 May 11;303(3):181-4.
Guo Q, Xie J, Chang X, Du H. Prostate apoptosis response-4 enhances secretion of amyloid beta peptide 1-42 in human neuroblastoma IMR-32 cells by a caspase-dependent pathway. J Biol Chem. 2001 May 11;276(19):16040-4.
Zöller B, Hock C, Kull HU. [Rational therapy of Alzheimer dementia based on current clinical studies] Schweiz Rundsch Med Prax. 2001 May 10;90(19):827-34.
Janek K, Rothemund S, Gast K, Beyermann M, Zipper J, Fabian H, Bienert M, Krause E. Study of the conformational transition of A beta(1-42) using D-amino acid replacement analogues. Biochemistry. 2001 May 8;40(18):5457-63.
Wang HX, Wahlin A, Basun H, Fastbom J, Winblad B, Fratiglioni L. Vitamin B(12) and folate in relation to the development of Alzheimer's disease. Neurology. 2001 May 8;56(9):1188-94.
Clapp-Lilly KL, Smith MA, Perry G, Harris PL, Zhu X, Duffy LK. Melatonin acts as antioxidant and pro-oxidant in an organotypic slice culture model of Alzheimer's disease. Neuroreport. 2001 May 8;12(6):1277-80.
Naidu A, Catalano R, Bales K, Wu S, Paul SM, Cordell B. Conversion of brain apolipoprotein E to an insoluble form in a mouse model of Alzheimer disease. Neuroreport. 2001 May 8;12(6):1265-70.
Haraguchi T, Ishizu H, Kawai K, Tanabe Y, Uehira K, Takehisa Y, Terada S, Tsuchiya K, Ikeda K, Kuroda S. Diffuse neurofibrillary tangles with calcification (a form of dementia): X-ray spectrometric evidence of lead accumulation in calcified regions. Neuroreport. 2001 May 8;12(6):1257-60.
Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. Proc Natl Acad Sci U S A. 2001 May 8;98(10):5815-20.
Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, Keller P, Runz H, Kuhl S, Bertsch T, von Bergmann K, Hennerici M, Beyreuther K, Hartmann T. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U S A. 2001 May 8;98(10):5856-61. ,
Perry RT, Collins JS, Harrell LE, Acton RT, Go RC. Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. Am J Med Genet. 2001 May 8;105(4):332-42. ,
Mann MB, Wu S, Rostamkhani M, Tourtellotte W, MacMurray J, Comings DE. Phenylethanolamine N-methyltransferase (PNMT) gene and early-onset Alzheimer disease. Am J Med Genet. 2001 May 8;105(4):312-6. ,
Walter J, Fluhrer R, Hartung B, Willem M, Kaether C, Capell A, Lammich S, Multhaup G, Haass C. Phosphorylation regulates intracellular trafficking of beta-secretase. J Biol Chem. 2001 May 4;276(18):14634-41.
Kim SH, Vlkolinsky R, Cairns N, Fountoulakis M, Lubec G. The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease. Life Sci. 2001 May 4;68(24):2741-50.
Hashimoto Y, Ito Y, Niikura T, Shao Z, Hata M, Oyama F, Nishimoto I. Mechanisms of neuroprotection by a novel rescue factor humanin from Swedish mutant amyloid precursor protein. Biochem Biophys Res Commun. 2001 May 4;283(2):460-8.
Terai K, Iwai A, Kawabata S, Sasamata M, Miyata K, Yamaguchi T. Apolipoprotein E deposition and astrogliosis are associated with maturation of beta-amyloid plaques in betaAPPswe transgenic mouse: Implications for the pathogenesis of Alzheimer's disease. Brain Res. 2001 May 4;900(1):48-56.
Masullo C, Daniele A, Fazio VM, Seripa D, Gravina C, Filippini V, Grossi D, Fragassi N, Nichelli P, Leone M, Gainotti G. The Apolipoprotein E genotype in patients affected by syndromes with focal cortical atrophy. Neurosci Lett. 2001 May 4;303(2):87-90.
Engidawork E, Gulesserian T, Seidl R, Cairns N, Lubec G. Expression of apoptosis related proteins in brains of patients with Alzheimer's disease. Neurosci Lett. 2001 May 4;303(2):79-82.
Walsh DM, Hartley DM, Condron MM, Selkoe DJ, Teplow DB. In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease. Biochem J. 2001 May 1;355(Pt 3):869-77.
Crott J, Fenech M. Preliminary study of the genotoxic potential of homocysteine in human lymphocytes in vitro. Mutagenesis. 2001 May;16(3):213-7.
de Picciotto J, Friedland D. Verbal fluency in elderly bilingual speakers: normative data and preliminary application to Alzheimer's disease. Folia Phoniatr Logop. 2001 May-Jun;53(3):145-52.
Kahana J. A new BACE is for therapy of Alzheimer's disease. Trends Cell Biol. 2001 May;11(5):192.
Fullerton SM, Shirman GA, Strittmatter WJ, Matthew WD. Impairment of the blood-nerve and blood-brain barriers in apolipoprotein e knockout mice. Exp Neurol. 2001 May;169(1):13-22.
Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, Smith MA. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci. 2001 May 1;21(9):3017-23.
Morgan C, Inestrosa NC. Interactions of laminin with the amyloid beta peptide. Implications for Alzheimer's disease. Braz J Med Biol Res. 2001 May;34(5):597-601.
Penninger JM, Irie-Sasaki J, Sasaki T, Oliveira-dos-Santos AJ. CD45: new jobs for an old acquaintance. Nat Immunol. 2001 May;2(5):389-96.
Yan JJ, Cho JY, Kim HS, Kim KL, Jung JS, Huh SO, Suh HW, Kim YH, Song DK. Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br J Pharmacol. 2001 May;133(1):89-96.
Ebadi M, Govitrapong P, Sharma S, Muralikrishnan D, Shavali S, Pellett L, Schafer R, Albano C, Eken J. Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease. Biol Signals Recept. 2001 May-Aug;10(3-4):224-53.
Urbanics R. Alzheimer's: IBC's ninth annual conference--gene discovery to therapeutic applications. IDrugs. 2001 May;4(5):522-3.
Zuliani G, Ble' A, Zanca R, Munari MR, Zurlo A, Vavalle C, Atti AR, Fellin R. Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia. Acta Neurol Scand. 2001 May;103(5):304-8. ,
Puglielli L, Kovacs DM. Alzheimer disease: 100 years later. Rev Med Chil. 2001 May;129(5):569-75.
Raskind MA, Peskind ER. Alzheimer's disease and related disorders. Med Clin North Am. 2001 May;85(3):803-17.
May PC. Current progress on new therapies for Alzheimer's disease. Drug Discov Today. 2001 May 1;6(9):459-462.
Jeong J, Gore JC, Peterson BS. Mutual information analysis of the EEG in patients with Alzheimer's disease. Clin Neurophysiol. 2001 May;112(5):827-35.
Hesse C, Nilsson CL, Blennow K, Davidsson P. Identification of the apolipoprotein E4 isoform in cerebrospinal fluid with preparative two-dimensional electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis. 2001 May;22(9):1834-7.
Dupuy AM, Badiou S, Ritchie K, Mas E, Descomps B, Cristol JP, Touchon J. Discrepancies between apolipoprotein E phenotyping and genotyping in the elderly. Clin Chem Lab Med. 2001 May;39(5):405-13.
Clippingdale AB, Wade JD, Barrow CJ. The amyloid-beta peptide and its role in Alzheimer's disease. J Pept Sci. 2001 May;7(5):227-49.
Larner AJ. N-terminal truncated amyloid beta-peptides and Alzheimer's disease. Neurobiol Aging. 2001 May-Jun;22(3):343, 345.
Qiu Z, Strickland DK, Hyman BT, Rebeck GW. Elevation of LDL receptor-related protein levels via ligand interactions in Alzheimer disease and in vitro. J Neuropathol Exp Neurol. 2001 May;60(5):430-40.
DeCarli C. The role of neuroimaging in dementia. Clin Geriatr Med. 2001 May;17(2):255-79.
Rockwood K, MacKnight C. Assessing the clinical importance of statistically significant improvement in anti-dementia drug trials. Neuroepidemiology. 2001 May;20(2):51-6.
Volicer L, Harper DG, Manning BC, Goldstein R, Satlin A. Sundowning and circadian rhythms in Alzheimer's disease. Am J Psychiatry. 2001 May 1;158(5):704-11.
Weller RO. How well does the CSF inform upon pathology in the brain in Creutzfeldt-Jakob and Alzheimer's diseases? J Pathol. 2001 May;194(1):1-3.
Russ C, Lovestone S, Powell JF. Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late onset Alzheimer's disease. Mol Psychiatry. 2001 May;6(3):320-4. ,
Martorell L, Virgos C, Valero J, Coll G, Figuera L, Joven J, Pocoví M, Labad A, Vilella E. Schizophrenic women with the APOE epsilon 4 allele have a worse prognosis than those without it. Mol Psychiatry. 2001 May;6(3):307-10.
Razani J, Boone KB, Miller BL, Lee A, Sherman D. Neuropsychological performance of right- and left-frontotemporal dementia compared to Alzheimer's disease. J Int Neuropsychol Soc. 2001 May;7(4):468-80.
De Felice FG, Houzel JC, Garcia-Abreu J, Louzada PR, Afonso RC, Meirelles MN, Lent R, Neto VM, Ferreira ST. Inhibition of Alzheimer's disease beta-amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapy. FASEB J. 2001 May;15(7):1297-9.
Silver MH, Jilinskaia E, Perls TT. Cognitive functional status of age-confirmed centenarians in a population-based study. J Gerontol B Psychol Sci Soc Sci. 2001 May;56(3):P134-40.
McKay D. Blocking Alzheimer's [correction of Altzheimer's]. Trends Biotechnol. 2001 May;19(5):162.
Oremus M, Wolfson C, Perrault A, Demers L, Momoli F, Moride Y. Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials. Dement Geriatr Cogn Disord. 2001 May-Jun;12(3):232-6.
Imamura T, Ishii K, Hirono N, Hashimoto M, Tanimukai S, Kazui H, Hanihara T, Sasaki M, Mori E. Occipital glucose metabolism in dementia with lewy bodies with and without Parkinsonism: a study using positron emission tomography. Dement Geriatr Cogn Disord. 2001 May-Jun;12(3):194-7.
Bobkova NV, Nesterova IV, Nesterov VV. The state of cholinergic structures in forebrain of bulbectomized mice. Bull Exp Biol Med. 2001 May;131(5):427-31.
Dilworth-Anderson P. Family issues and the care of persons with Alzheimer's disease. Aging Ment Health. 2001 May;5 Suppl 1:S49-51.
Ventura M, Sternon J. [Cholinesterase inhibitors in Alzheimer's disease] J Pharm Belg. 2001 May-Jun;56(3):62-8.
Sobów TM, Maczkiewicz M, Magierski R, Strzelecki D, Wojtera M, Karlinska I, Kloszewska I. ["7 Minute Screening. Part II: the evaluation of the test sensitivity and specificity as compared to Mini-Mental State examination] Psychiatr Pol. 2001 May-Jun;35(3):475-81.
Gahtan E, Overmier JB. Performance more than working memory disrupted by acute systemic inflammation in rats in appetitive tasks. Physiol Behav. 2001 May;73(1-2):201-10.
Frey J. [Is there sugar in the Alzheimer's disease?] Ann Biol Clin (Paris). 2001 May-Jun;59(3):253-7.
Li Y, Liu YW, Cordell B. Novel functional assay for proteases and modulators. Application in beta-secretase studies. Mol Biotechnol. 2001 May;18(1):1-10.
de la Monte SM, Wands JR. Neurodegeneration changes in primary central nervous system neurons transfected with the Alzheimer-associated neuronal thread protein gene. Cell Mol Life Sci. 2001 May;58(5-6):844-9.
Danysz W. Neurotoxicity as a mechanism for neurodegenerative disorders: basic and clinical aspects. Expert Opin Investig Drugs. 2001 May;10(5):985-9.
Müller EE. [Steroids, cognitive processes and aging] Recenti Prog Med. 2001 May;92(5):362-72.
Fillenbaum GG, Heyman A, Huber MS, Ganguli M, Unverzagt FW. Performance of elderly African American and White community residents on the CERAD Neuropsychological Battery. J Int Neuropsychol Soc. 2001 May;7(4):502-9.
Brinton RD. Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer's disease: recent insights and remaining challenges. Learn Mem. 2001 May-Jun;8(3):121-33.
Kitayama N, Matsuda H, Ohnishi T, Kogure D, Asada T, Uno M, Kamijima K. Measurements of both hippocampal blood flow and hippocampal gray matter volume in the same individuals with Alzheimer's disease. Nucl Med Commun. 2001 May;22(5):473-7.
Román G. Diagnosis of vascular dementia and Alzheimer's disease. Int J Clin Pract Suppl. 2001 May;(120):9-13.
Bennett D. Public health importance of vascular dementia and Alzheimer's disease with cerebrovascular disease. Int J Clin Pract Suppl. 2001 May;(120):41-8.
Maelicke A. The pharmacological rationale for treating vascular dementia with galantamine (Reminyl). Int J Clin Pract Suppl. 2001 May;(120):24-8.
Erkinjuntti T. Clinical deficits of Alzheimer's disease with cerebrovascular disease and probable VaD. Int J Clin Pract Suppl. 2001 May;(120):14-23.
Small G. Meeting the challenges of vascular dementia. Introduction. Int J Clin Pract Suppl. 2001 May;(120):1-4.
Gauthier E, Fortier I, Courchesne F, Pepin P, Mortimer J, Gauvreau D. Environmental pesticide exposure as a risk factor for Alzheimer's disease: a case-control study. Environ Res. 2001 May;86(1):37-45.
Verkkoniemi A, Kalimo H, Paetau A, Somer M, Iwatsubo T, Hardy J, Haltia M. Variant Alzheimer disease with spastic paraparesis: neuropathological phenotype. J Neuropathol Exp Neurol. 2001 May;60(5):483-92.
Espinosa B, Zenteno R, Mena R, Robitaille Y, Zenteno E, Guevara J. O-Glycosylation in sprouting neurons in Alzheimer disease, indicating reactive plasticity. J Neuropathol Exp Neurol. 2001 May;60(5):441-8.
Bigio EH, Vono MB, Satumtira S, Adamson J, Sontag E, Hynan LS, White CL, Baker M, Hutton M. Cortical synapse loss in progressive supranuclear palsy. J Neuropathol Exp Neurol. 2001 May;60(5):403-10.
Bourdel-Marchasson I, Delmas-Beauvieux MC, Peuchant E, Richard-Harston S, Decamps A, Reignier B, Emeriau JP, Rainfray M. Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing. 2001 May;30(3):235-41.
Shoji M. [Research progress of Alzheimer's disease-biological marker] Nippon Ronen Igakkai Zasshi. 2001 May;38(3):291-2.
Holroyd S, Shepherd ML. Alzheimer's disease: a review for the ophthalmologist. Surv Ophthalmol. 2001 May-Jun;45(6):516-24.
Jayasena UL, Gribble SK, McKenzie A, Beyreuther K, Masters CL, Underwood JR. Identification of structural variations in the carboxyl terminus of Alzheimer's disease-associated beta A4[1-42] amyloid using a monoclonal antibody. Clin Exp Immunol. 2001 May;124(2):297-305.
Colomer Rubio E, Sánchez Roy R, Pareja Martínez A, Perla C, Villarroya T, Cerdá Nicolás M, Carbonell C. [Alien hand syndrome in Creutzfeldt-Jakob disease] Neurologia. 2001 May;16(5):223-6.
Kim SY, Caine ED, Currier GW, Leibovici A, Ryan JM. Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research. Am J Psychiatry. 2001 May;158(5):712-7.
Wyss-Coray T, Lin C, Yan F, Yu GQ, Rohde M, McConlogue L, Masliah E, Mucke L. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat Med. 2001 May;7(5):612-8.
Weninger SC, Yankner BA. Inflammation and Alzheimer disease: the good, the bad, and the ugly. Nat Med. 2001 May;7(5):527-8.
Chapman PF, Falinska AM, Knevett SG, Ramsay MF. Genes, models and Alzheimer's disease. Trends Genet. 2001 May;17(5):254-61.
Green KN, Peers C. Amyloid beta peptides mediate hypoxic augmentation of Ca(2+) channels. J Neurochem. 2001 May;77(3):953-6.
Bozyczko-Coyne D, O'Kane TM, Wu ZL, Dobrzanski P, Murthy S, Vaught JL, Scott RW. CEP-1347/KT-7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Abeta-induced cortical neuron apoptosis. J Neurochem. 2001 May;77(3):849-63.
Wang MJ, Huang HM, Chen HL, Kuo JS, Jeng KC. Dehydroepiandrosterone inhibits lipopolysaccharide-induced nitric oxide production in BV-2 microglia. J Neurochem. 2001 May;77(3):830-8.
Szili-Török T, Kálmán J, Paprika D, Dibó G, Rózsa Z, Rudas L. Depressed baroreflex sensitivity in patients with Alzheimer's and Parkinson's disease. Neurobiol Aging. 2001 May-Jun;22(3):435-8.
Stalder M, Deller T, Staufenbiel M, Jucker M. 3D-Reconstruction of microglia and amyloid in APP23 transgenic mice: no evidence of intracellular amyloid. Neurobiol Aging. 2001 May-Jun;22(3):427-34.
Ishunina TA, Swaab DF. Increased expression of estrogen receptor alpha and beta in the nucleus basalis of Meynert in Alzheimer's disease. Neurobiol Aging. 2001 May-Jun;22(3):417-26.
Scacchi R, Ruggeri M, Gambina G, Martini MC, Ferrari G, Corbo RM. Plasma alpha1-antichymotrypsin in Alzheimer's disease; relationships with APOE genotypes. Neurobiol Aging. 2001 May-Jun;22(3):413-6. ,
in't Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging. 2001 May-Jun;22(3):407-12.
Nemes Z, Fésüs L, Egerházi A, Keszthelyi A, Degrell IM. N(epsilon)(gamma-glutamyl)lysine in cerebrospinal fluid marks Alzheimer type and vascular dementia. Neurobiol Aging. 2001 May-Jun;22(3):403-6.
Shuvaev VV, Laffont I, Serot JM, Fujii J, Taniguchi N, Siest G. Increased protein glycation in cerebrospinal fluid of Alzheimer's disease. Neurobiol Aging. 2001 May-Jun;22(3):397-402.
Johnson RJ, Xiao G, Shanmugaratnam J, Fine RE. Calreticulin functions as a molecular chaperone for the beta-amyloid precursor protein. Neurobiol Aging. 2001 May-Jun;22(3):387-95.
Ishii K, Lippa C, Tomiyama T, Miyatake F, Ozawa K, Tamaoka A, Hasegawa T, Fraser PE, Shoji S, Nee LE, Pollen DA, St George-Hyslop PH, Ii K, Ohtake T, Kalaria RN, Rossor MN, Lantos PL, Cairns NJ, Farrer LA, Mori H. Distinguishable effects of presenilin-1 and APP717 mutations on amyloid plaque deposition. Neurobiol Aging. 2001 May-Jun;22(3):367-76.
Scheff SW, Price DA, Sparks DL. Quantitative assessment of possible age-related change in synaptic numbers in the human frontal cortex. Neurobiol Aging. 2001 May-Jun;22(3):355-65.
Terry RD, Katzman R. Life span and synapses: will there be a primary senile dementia? Neurobiol Aging. 2001 May-Jun;22(3):347-8; discussion 353-4.
Martin LJ. Neuronal cell death in nervous system development, disease, and injury (Review). Int J Mol Med. 2001 May 1;7(5):455-78.
Tomita M, Sugi H, Ozawa K, Tsong TY, Yoshimura T. Targeting antigen-specific receptors on B lymphocytes to generate high yields of specific monoclonal antibodies directed against biologically active lower antigenic peptides within presenilin 1. J Immunol Methods. 2001 May 1;251(1-2):31-43.
Okuda B, Tachibana H, Kawabata K, Takeda M, Sugita M. Comparison of brain perfusion in corticobasal degeneration and Alzheimer's disease. Dement Geriatr Cogn Disord. 2001 May-Jun;12(3):226-31.
Yoo BC, Cairns N, Fountoulakis M, Lubec G. Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (beta-SNAP), gamma-SNAP and synaptotagmin I in brain of patients with Down syndrome and Alzheimer's disease. Dement Geriatr Cogn Disord. 2001 May-Jun;12(3):219-25.
Sjöbeck M, Englund E. Alzheimer's disease and the cerebellum: a morphologic study on neuronal and glial changes. Dement Geriatr Cogn Disord. 2001 May-Jun;12(3):211-8.
Barber R, McKeith IG, Ballard C, Gholkar A, O'Brien JT. A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: magnetic resonance imaging volumetric study. Dement Geriatr Cogn Disord. 2001 May-Jun;12(3):198-205.
Pagani M, Salmaso D, Ramström C, Jonsson C, Lundqvist R, Thurfjell L, Schnell PO, Wägner A, Jacobsson H, Larsson SA. Mapping pathological (99m)Tc-d,l-hexamethylpropylene amine oxime uptake in Alzheimer's disease and frontal lobe dementia with SPECT. Dement Geriatr Cogn Disord. 2001 May-Jun;12(3):177-84.
Sjögren M, Davidsson P, Tullberg M, Minthon L, Wallin A, Wikkelso C, Granérus AK, Vanderstichele H, Vanmechelen E, Blennow K. Both total and phosphorylated tau are increased in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2001 May;70(5):624-30. ,
Migneco O, Benoit M, Koulibaly PM, Dygai I, Bertogliati C, Desvignes P, Robert PH, Malandain G, Bussiere F, Darcourt J. Perfusion brain SPECT and statistical parametric mapping analysis indicate that apathy is a cingulate syndrome: a study in Alzheimer's disease and nondemented patients. Neuroimage. 2001 May;13(5):896-902.
Crum WR, Scahill RI, Fox NC. Automated hippocampal segmentation by regional fluid registration of serial MRI: validation and application in Alzheimer's disease. Neuroimage. 2001 May;13(5):847-55.
Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Curr Opin Hematol. 2001 May;8(3):131-6.
Stewart R, Richards M, Brayne C, Mann A. Cognitive function in UK community-dwelling African Caribbean elders: normative data for a test battery. Int J Geriatr Psychiatry. 2001 May;16(5):518-27.
Gray AJ, Staples V, Murren K, Dhariwal A, Bentham P. Olfactory identification is impaired in clinic-based patients with vascular dementia and senile dementia of Alzheimer type. Int J Geriatr Psychiatry. 2001 May 1;16(5):513-7.
Ballard C, O'Brien J, Morris CM, Barber R, Swann A, Neill D, McKeith I. The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease. Int J Geriatr Psychiatry. 2001 May;16(5):499-503.
Ballard C, Walker M, O'Brien J, Rowan E, McKeith I. The characterisation and impact of 'fluctuating' cognition in dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry. 2001 May;16(5):494-8.
Li Y, Meyer JS, Thornby J. Depressive symptoms among cognitively normal versus cognitively impaired elderly subjects. Int J Geriatr Psychiatry. 2001 May;16(5):455-61.
Woods YL, Cohen P, Becker W, Jakes R, Goedert M, Wang X, Proud CG. The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase. Biochem J. 2001 May 1;355(Pt 3):609-15.
Royet JP, Croisile B, Williamson-Vasta R, Hibert O, Serclerat D, Guerin J. Rating of different olfactory judgements in Alzheimer's disease. Chem Senses. 2001 May;26(4):409-17.
Cifuentes F, González CE, Fiordelisio T, Guerrero G, Lai FA, Hernández-Cruz A. A ryanodine fluorescent derivative reveals the presence of high-affinity ryanodine binding sites in the Golgi complex of rat sympathetic neurons, with possible functional roles in intracellular Ca(2+) signaling. Cell Signal. 2001 May;13(5):353-62.
Galasko D. New approaches to diagnose and treat Alzheimer's disease: a glimpse of the future. Clin Geriatr Med. 2001 May;17(2):393-410.
Tariot PN, Ryan JM, Porsteinsson AP, Loy R, Schneider LS. Pharmacologic therapy for behavioral symptoms of Alzheimer's disease. Clin Geriatr Med. 2001 May;17(2):359-76.
Schneider LS. Treatment of Alzheimer's disease with cholinesterase inhibitors. Clin Geriatr Med. 2001 May;17(2):337-58.
Salmon DP, Lange KL. Cognitive screening and neuropsychological assessment in early Alzheimer's disease. Clin Geriatr Med. 2001 May;17(2):229-54.
Dickson DW. Neuropathology of Alzheimer's disease and other dementias. Clin Geriatr Med. 2001 May;17(2):209-28.
Delatour B, Mercken L, El Hachimi KH, Colle MA, Pradier L, Duyckaerts C. FE65 in Alzheimer's disease: neuronal distribution and association with neurofibrillary tangles. Am J Pathol. 2001 May;158(5):1585-91.
Han X, Holtzman DM, McKeel DW. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J Neurochem. 2001 May;77(4):1168-80. ,
Villa A, Latasa MJ, Pascual A. Nerve growth factor modulates the expression and secretion of beta-amyloid precursor protein through different mechanisms in PC12 cells. J Neurochem. 2001 May;77(4):1077-84.
Nasir J. New Alzheimer's disease susceptibility locus on chromosome 10q. Clin Genet. 2001 May;59(5):303-4.
Demissie S, Green RC, Mucci L, Tziavas S, Martelli K, Bang K, Coons L, Bourque S, Buchillon D, Johnson K, Smith T, Sharrow N, Lautenschlager N, Friedland R, Cupples LA, Farrer LA. Reliability of information collected by proxy in family studies of Alzheimer's disease. Neuroepidemiology. 2001 May;20(2):105-11.
Kawamura Y, Kikuchi A, Takada R, Takada S, Sudoh S, Shibamoto S, Yanagisawa K, Komano H. Inhibitory effect of a presenilin 1 mutation on the Wnt signalling pathway by enhancement of beta-catenin phosphorylation. Eur J Biochem. 2001 May;268(10):3036-41.
Querfurth HW, Suhara T, Rosen KM, McPhie DL, Fujio Y, Tejada G, Neve RL, Adelman LS, Walsh K. Beta-amyloid peptide expression is sufficient for myotube death: implications for human inclusion body myopathy. Mol Cell Neurosci. 2001 May;17(5):793-810.
Terry RD. An honorable compromise regarding amyloid in Alzheimer disease. Ann Neurol. 2001 May;49(5):684.
Flowers JM, Powell JF, Leigh PN, Andersen P, Shaw CE. Intron 7 retention and exon 9 skipping EAAT2 mRNA variants are not associated with amyotrophic lateral sclerosis. Ann Neurol. 2001 May;49(5):643-9.
Smyer MA. Russian dolls and Chinese boxes: the ecology of Alzheimer's disease research. Aging Ment Health. 2001 May;5 Suppl 1(2):149-152.
Newcomer RJ, Fox PJ, Harrington CA. Health and long-term care for people with Alzheimer's disease and related dementias: policy research issues. Aging Ment Health. 2001 May;5 Suppl 1(2):124-137.
Zarit SH, Leitsch SA. Developing and evaluating community based intervention programs for Alzheimer's patients and their caregivers. Aging Ment Health. 2001 May;5 Suppl 1(2):84-98.
Calkins MP. The physical and social environment of the person with Alzheimer's disease. Aging Ment Health. 2001 May;5 Suppl 1(2):74-78.
Stone RI. Alzheimer's disease and related dementias: important policy issues. Aging Ment Health. 2001 May;5 Suppl 1(2):146-148.
Riggs JA. The health and long-term care policy challenges of Alzheimer's disease. Aging Ment Health. 2001 May;5 Suppl 1(2):138-145.
Brawley EC. Environmental design for Alzheimer's disease: a quality of life issue. Aging Ment Health. 2001 May;5 Suppl 1(2):79-83.
Charness N, Holley P. Human factors and environmental support in Alzheimer's disease. Aging Ment Health. 2001 May;5 Suppl 1(2):65-73.
Montgomery RJ, Williams KN. Implications of differential impacts of care-giving for future research on Alzheimer care. Aging Ment Health. 2001 May;5 Suppl 1(2):23-34.
Post SG. Comments on research in the social sciences pertaining to Alzheimer's disease: a more humble approach. Aging Ment Health. 2001 May;5 Suppl 1(2):17-19.
Lawton MP. The physical environment of the person with Alzheimer's disease. Aging Ment Health. 2001 May;5 Suppl 1(2):56-64.
Dilworth-Anderson P. Family issues and the care of persons with Alzheimer's disease. Aging Ment Health. 2001 May;5 Suppl 1(2):49-51.
Woods RT. Discovering the person with Alzheimer's disease: cognitive, emotional and behavioural aspects. Aging Ment Health. 2001 May;5 Suppl 1(2):7-16.
Pearlin LI, Harrington C, Lawton MP, Montgomery RJ, Zarit SH. An overview of the social and behavioral consequences of Alzheimer's disease. Aging Ment Health. 2001 May;5 Suppl 1(2):3-6.
Thatte U. AN-1792 (Elan). Curr Opin Investig Drugs. 2001 May;2(5):663-7.
Niskakangas T, Ohman J, Niemelä M, Ilveskoski E, Kunnas TA, Karhunen PJ. Association of apolipoprotein E polymorphism with outcome after aneurysmal subarachnoid hemorrhage: a preliminary study. Stroke. 2001 May;32(5):1181-4.
Mast BT, Fitzgerald J, Steinberg J, MacNeill SE, Lichtenberg PA. Effective screening for Alzheimer's disease among older African Americans. Clin Neuropsychol. 2001 May;15(2):196-202.
Brawley EC. Environmental design for Alzheimer's disease: a quality of life issue. Aging Ment Health. 2001 May;5 Suppl 1:S79-83.
Calkins MP. The physical and social environment of the person with Alzheimer's disease. Aging Ment Health. 2001 May;5 Suppl 1:S74-8.
Woods RT. Discovering the person with Alzheimer's disease: cognitive, emotional and behavioural aspects. Aging Ment Health. 2001 May;5 Suppl 1:S7-16.
Lawton MP. The physical environment of the person with Alzheimer's disease. Aging Ment Health. 2001 May;5 Suppl 1:S56-64.
No comments:
Post a Comment